Detecting fetal blood loss in pregnancy to diagnose newborn jaundice
Part of Blood & lymphatic, Genetic & congenital, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study tests a new method to measure how much fetal blood leaks into the mother's bloodstream, which can cause severe jaundice in newborns. It may help doctors diagnose hemolytic disease of the newborn earlier and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby and at least 20 weeks along
- You have had belly trauma, a procedure like amniocentesis, or certain pregnancy problems such as placental abruption or preeclampsia
- Your baby shows signs of anemia, growth problems, or abnormal heart rate
- Your blood type is not compatible with your baby's (for example, Rh-negative or ABO mismatch) and you have tested positive for antibodies early in pregnancy
- You do not have a severe blood disorder (like clotting problems) or an autoimmune disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a breath-related measurement (from the air you exhale) to help diagnose and guide treatment for jaundice in certain newborns. It may help the care team better decide what care you need after birth, especially when jaundice is related to blood type mismatch.
This trial uses a special breath test (ETCOc) to measure jaundice in newborns, aiming to improve diagnosis and treatment. It may help doctors decide when treatment is needed.
This trial studies if a blood test measuring the ratio of two proteins can better predict brain damage from severe jaundice than the current standard test. It aims to help doctors identify babies who need faster treatment.
This study tracks pregnancies affected by hemolytic disease of the fetus and newborn (HDFN). It collects information to better understand the condition and improve care. You may join if you are pregnant with a history of a prior affected pregnancy and have a current antibody that could harm your baby.
This study tests a device that measures jaundice (yellowing of the skin) through the skin rather than with a blood test. It may help newborns avoid a needle stick.
This study tests a painless device that checks for anemia (low red blood cells) in babies without needing a blood draw. If your baby is in the NICU and already needs a blood test, this device might be able to replace it.
Hear when a new Hemolytic Disease of the Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.